Michael Copland, MD, Paul Komenda, MD, Eric D

Slides:

Advertisements

Similar presentations

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Advertisements

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Intensive Hemodialysis, Treatment Complications and Tolerability

Intensive Hemodialysis, Treatment Complications and Tolerability

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA

Intensive Hemodialysis and Health-related Quality of Life

Intensive Hemodialysis and Health-related Quality of Life

Renal Function Testing

Intensive Hemodialysis and Potential Risks with Increasing Treatment

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

Bakris GL, Burkhart JM, Weinhandl ED, McCullough PA, Kraus MA

Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A

Peritoneal dialysis American Journal of Kidney Diseases

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Phosphate Kinetic Models in Hemodialysis: A Systematic Review

Regional Differences in the Associations Between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the Dialysis Outcomes and.

Development of Reduced Kidney Function in Rheumatoid Arthritis

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

Intensive Hemodialysis and Health-Related Quality of Life

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Awareness and Knowledge of Clinical Practice Guidelines for CKD Among Internal Medicine Residents: A National Online Survey Varun Agrawal, MD, Amit K.

Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial Hao Yan, MD, Wei Fang, MD,

Sevelamer Prescriptions After Reporting of the Dialysis Clinical Outcomes Revisited (DCOR) Trial Findings: An Analysis of 5,495 Patients Receiving Maintenance.

Evaluation of the Potential Living Kidney Donor

Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care Douglas S.

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Wayne Trebbin, MD, Peter Monteleone, MD

Salt and Hypertension American Journal of Kidney Diseases

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis George Thomas, MD, MPH, Ethan M. Balk, MD,

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

This Month in AJKD American Journal of Kidney Diseases

Sankar D. Navaneethan, MD, MPH, Suetonia C. Palmer, MBChB, Jonathan C

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Kidney Disease Among African Americans: A Population Perspective

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

A Role for Bromine Deficiency in Sleep Disturbances of Long-Term Dialysis Patients Caterina Canavese, MD, Ester De Costanzi, MD, Piero Stratta, MD, Enrico.

The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral and Bone Disorder.

Study Designs in Patient-Oriented Research

The Precision of Standardized Hospitalization, Readmission, and Mortality Ratios for Dialysis Facilities Steven M. Brunelli, MD, MSCE, Adam G. Walker,

Drug Dose Adjustments in Patients With Renal Impairment

Dennis G. Moledina, MD, Mark A. Perazella, MD

Hyperaluminemia During Long-term Dialysis: Still Relevant Today

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Intensive Hemodialysis and Potential Risks With Increasing Treatment

George L. Bakris, MD, John M. Burkart, MD, Eric D

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Risk for Incident Renal Dialysis in a Managed Care Population

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Making Music American Journal of Kidney Diseases

Michael Allon, MD American Journal of Kidney Diseases

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Ronald L. Pisoni, PhD, MS, Brenda W. Gillespie, PhD, David M

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

Soluble CD14 and Endotoxin Levels in Hemodialysis Patients: A Tale of 2 Molecules Victor F. Seabra, MD, George Thomas, MD, MPH, Bertrand L. Jaber, MD,

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

Presentation transcript:

Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use Michael Copland, MD, Paul Komenda, MD, Eric D. Weinhandl, PhD, MS, Peter A. McCullough, MD, MPH, Jose A. Morfin, MD American Journal of Kidney Diseases Volume 68, Issue 5, Pages S24-S32 (November 2016) DOI: 10.1053/j.ajkd.2016.05.024 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Distribution of 3-month mean serum phosphorus levels in the Dialysis Outcomes and Practice Patterns Study Practice Monitor, December 2015.10 American Journal of Kidney Diseases 2016 68, S24-S32DOI: (10.1053/j.ajkd.2016.05.024) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Medicare Part D gross costs per patient-year for phosphate binders, by dialysis provider organization or class, 2011. Abbreviations: DCI, Dialysis Clinic, Inc; FDF, free-standing dialysis facility; HDF, hospital-based dialysis facility; SDO, small dialysis organization. American Journal of Kidney Diseases 2016 68, S24-S32DOI: (10.1053/j.ajkd.2016.05.024) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Effects of intensive versus conventional hemodialysis on serum phosphorus levels in the Frequent Hemodialysis Network (FHN) Daily Trial,35 FHN Nocturnal Trial,35 and Canadian trial of nocturnal hemodialysis.36 Estimated treatment effects (solid dots) and associated 95% confidence intervals (solid lines) are displayed at the bottom. American Journal of Kidney Diseases 2016 68, S24-S32DOI: (10.1053/j.ajkd.2016.05.024) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 4 Mean equivalent phosphorus binding dose for intensive versus conventional hemodialysis in the Frequent Hemodialysis Network (FHN) Daily Trial.35 Dashed bars span 1 standard deviation above and below the mean. American Journal of Kidney Diseases 2016 68, S24-S32DOI: (10.1053/j.ajkd.2016.05.024) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 5 Distribution of equivalent phosphorus binding dose (EQBD) for intensive versus conventional hemodialysis in the Frequent Hemodialysis Network (FHN) Nocturnal Trial.35 American Journal of Kidney Diseases 2016 68, S24-S32DOI: (10.1053/j.ajkd.2016.05.024) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions